| Psychological aspects of screening in families with hereditary prostate cancer. | |
| | |
MedLine Citation:
|
PMID: 12745735 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Approximately 5-10% of prostate cancer cases are caused by dominantly inherited susceptibility to the disease. Although advances have been made in research concerning the genetic mechanisms of hereditary prostate cancer, little is known about the psychological consequences. The aim of this study was to assess possible negative psychological effects of screening for prostate cancer in a high-risk population. MATERIAL AND METHODS: This study was based on a previous study of risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. The present study included 87 men from the previous study who were screened regularly for prostate cancer. Of these, 74 men agreed to receive two further questionnaires, both of which included the Hospital Anxiety and Depression Scale (HAD) and the Impact of Event Scale (IES), one of which was filled in on the day of the next screening visit and the other 4-6 weeks later. RESULTS: The response rate was 77% (57/74). There were no statistically significant differences in total or subscale HAD or IES scores between the two points of measurement. There was a trend towards slightly higher HAD scores on the day of the screening visit, but the difference was so small that we did not consider it clinically relevant. In an attempt to identify risk factors for a negative impact of screening several subgroup analyses were performed, but none of these subgroups had significantly higher scores on the day of the visit than afterwards. CONCLUSION: Most men with a high hereditary risk of developing prostate cancer do not experience severe psychological adverse effects resulting from attendance for screening. |
| | |
Authors:
|
Ola Bratt; Monica Emanuelsson; Henrik Grönberg |
Related Documents
:
|
12497025 - Attitudes and use of alternative therapies in uk prostate cancer patients-isn't it time... 18651985 - Proscan for men: randomised controlled trial of a decision support intervention for men... 18783735 - The prostate cancer intervention versus observation trial:va/nci/ahrq cooperative studi... 17333605 - Community attitudes towards the early detection of cancer in victoria, australia. 8893325 - Psychiatric and psychosocial concomitants of abnormal illness behaviour in patients wit... 6275965 - Why patients seek unproven cancer remedies: a psychological perspective. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Scandinavian journal of urology and nephrology Volume: 37 ISSN: 0036-5599 ISO Abbreviation: Scand. J. Urol. Nephrol. Publication Date: 2003 |
Date Detail:
|
Created Date: 2003-05-16 Completed Date: 2003-06-10 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0114501 Medline TA: Scand J Urol Nephrol Country: Sweden |
Other Details:
|
Languages: eng Pagination: 5-9 Citation Subset: IM |
Affiliation:
|
Unit for Urology, Helsingborg Hospital, Helsingborg, Sweden. ola.bratt@helsingborgslasarett.se |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Family / psychology* Genetic Diseases, Inborn / diagnosis*, genetics, psychology* Humans Male Mass Screening / psychology* Middle Aged Office Visits Prostatic Neoplasms / diagnosis*, genetics, psychology* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Multiple myeloma presenting as bilateral renal complex stones.
Next Document: Postoperative radiotherapy after prostatectomy--a review.